BridgeBio Pharma Financials

BridgeBio Pharma Stock Summary

BridgeBio Pharma competes with CHIBA BANK, National Bank, LG Electronics, STMicroelectronics, and Universal Electronics. BridgeBio Pharma, Inc. engages in the discovery, development, and delivery of various medicines for genetic diseases. The company was founded in 2015 and is headquartered in Palo Alto, California. BRIDGEBIO PHARMA operates under Biotechnology classification in Germany and is traded on Frankfurt Stock Exchange. It employs 385 people.

BridgeBio Pharma Key Financial Ratios

There are many critical financial ratios that BridgeBio Pharma's investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that BridgeBio Pharma reports annually and quarterly.

BridgeBio Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining BridgeBio Pharma's current stock value. Our valuation model uses many indicators to compare BridgeBio Pharma value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across BridgeBio Pharma competition to find correlations between indicators driving BridgeBio Pharma's intrinsic value. More Info.BridgeBio Pharma is currently under evaluation in return on asset category among its peers. It also is currently under evaluation in profit margin category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the BridgeBio Pharma's earnings, one of the primary drivers of an investment's value.

Along with financial statement analysis, the daily predictive indicators of BridgeBio Pharma help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of BridgeBio Pharma. We use our internally-developed statistical techniques to arrive at the intrinsic value of BridgeBio Pharma based on widely used predictive technical indicators. In general, we focus on analyzing BridgeBio Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build BridgeBio Pharma's daily price indicators and compare them against related drivers.

When running BridgeBio Pharma's price analysis, check to measure BridgeBio Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BridgeBio Pharma is operating at the current time. Most of BridgeBio Pharma's value examination focuses on studying past and present price action to predict the probability of BridgeBio Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BridgeBio Pharma's price. Additionally, you may evaluate how the addition of BridgeBio Pharma to your portfolios can decrease your overall portfolio volatility.